Pityriasis rubra pilaris post-infection due COVID-19: case report.

Journal: Colombia Medica (Cali, Colombia)
Treatment Used: Rehydrating Cream, Cetirizine, and Prednisolone
Number of Patients: 1
Published:
MediFind Summary

Summary: This case report describes a 32-month-old boy diagnosed with COVID-19 who developed a Pityriasis rubra pilaris post-infection treated with rehydrating cream, cetirizine, and prednisolone.

Conclusion: A 32-month-old boy with COVID-19 who developed a Pityriasis rubra pilaris post-infection was successfully treated with rehydrating cream, cetirizine, and prednisolone.

Abstract

Methods: 32-month-old boy, IgG positive for SARS-CoV-2, presented to the emergency department with dermatologic lesions.

Results: Four days before admission, he presented skin eruptions with redness and pruritus on hands and feet. Generalized papular erythema was evidenced, upper extremities with diffuse erythematosquamous plaques, palmoplantar keratoderma, so he was evaluated by a dermatologist who diagnosed pityriasis rubra pilaris. Results: rehydrating cream, cetirizine 0.5 mg/kg/day every two days, and prednisolone 2 mg/kg/day in the morning. He was discharged after 14 days, the patient presented clinical improvement, but the erythematous lesion persisted on the trunk and extremities. In the evaluation, after three months, the patient did not show the described lesions, evidencing an improvement and clinical resolution of the dermatological problems.

Conclusions: We report a patient with pityriasis rubra piloris associated with a post-infection by SARS-CoV-2 that had not been described before.

Authors
Franklin Aguilar Gamboa, Dennis Cubas Alarcon, Miguel Villegas Chiroque, Virgilio Failoc Rojas

Similar Latest Advances